We successfully identified the subpopulation of TNBC tumor cells, C3, that express MHC-II genes and actively interact with immune cells and sensitivity to IFN-γ, which suggests its functional importance in repressing tumor progression. This evidence concerns the gene IFNG and neoplasm.